logo
ProjectForthcoming

Nanodomain Engineering using a X-omics blueprint of the NK cell Surface

Forthcoming · Netherlands

Source: EU Funding & Tenders Portal

Natural killer (NK) cells hold enormous promise for cancer therapy, which is explored in nearly 400 clinical trials. Yet, on average only about 40% of patients respond to treatment and it remains difficult to predict why. This challenge stems from a fundamental unknown: how do NK cells decide whether to kill a tumor cell? Traditional models assume this decision is governed by a simple balance of a

Status
Prospective
Location
Netherlands
Updated
19 Nov 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about Nanodomain Engineering using a X-omics blueprint of the NK cell Surface

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “Nanodomain Engineering using a X-omics blueprint of the NK cell Surface” is an infrastructure initiative, located in Netherlands. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

forthcoming

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

Natural killer (NK) cells hold enormous promise for cancer therapy, which is explored in nearly 400 clinical trials. Yet, on average only about 40% of patients respond to treatment and it remains difficult to predict why. This challenge stems from a fundamental unknown: how do NK cells decide whether to kill a tumor cell? Traditional models assume this decision is governed by a simple balance of activating and inhibitory receptors, but mounting evidence suggests a more intricate mechanism: the nanoscale spatial organization of these receptors appears to encode specific instructions that determine NK cell behavior. I project that a proximity labeling platform I recently developed represents a key foundation to decipher this code. In my ERC project called NEXUS I will: 1) Apply a new cutting-edge nanoscale proteomics approach to systematically chart the nanoscale distribution of key NK receptors and their coregulators on the membrane of cultured and primary human NK cells across various activating and repressive conditions. 2) Develop a new spatial interaction proteomics approach to define which receptor-ligand interactions guide NK recognition of tumor targets. 3) Engineer NK cells with optogenetically tunable receptor clustering to causally test how specific receptor organizations govern NK cell activation, immune synapse formation, and target killing. Together, NEXUS will redefine our understanding of NK cell biology and establish a generalizable framework for how immune cells interpret complex signals through spatial organization. This could open an entirely new dimension of immune regulation and reshape the way we think about immune decision-making, and move immunotherapy design beyond trial-and-error towards new rational, spatially informed NK-cell therapies with transformative potential for cancer treatment.

Location

Country

Netherlands

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Article published date

2026-11-15

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project